These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34153688)

  • 1. Differential trajectories of hypometabolism across cognitively-defined Alzheimer's disease subgroups.
    Groot C; Risacher SL; Chen JQA; Dicks E; Saykin AJ; Mac Donald CL; Mez J; Trittschuh EH; Mukherjee S; Barkhof F; Scheltens P; van der Flier WM; Ossenkoppele R; Crane PK;
    Neuroimage Clin; 2021; 31():102725. PubMed ID: 34153688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative longitudinal interrelationships between brain metabolism and amyloid deposition during a 2-year follow-up in patients with early Alzheimer's disease.
    Förster S; Yousefi BH; Wester HJ; Klupp E; Rominger A; Förstl H; Kurz A; Grimmer T; Drzezga A
    Eur J Nucl Med Mol Imaging; 2012 Dec; 39(12):1927-36. PubMed ID: 22926714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology.
    Laforce R; Tosun D; Ghosh P; Lehmann M; Madison CM; Weiner MW; Miller BL; Jagust WJ; Rabinovici GD
    Neuroimage Clin; 2014; 4():508-16. PubMed ID: 24818077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer's disease.
    Strom A; Iaccarino L; Edwards L; Lesman-Segev OH; Soleimani-Meigooni DN; Pham J; Baker SL; Landau SM; Jagust WJ; Miller BL; Rosen HJ; Gorno-Tempini ML; Rabinovici GD; La Joie R;
    Brain; 2022 Apr; 145(2):713-728. PubMed ID: 34373896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential patterns of gray matter volumes and associated gene expression profiles in cognitively-defined Alzheimer's disease subgroups.
    Groot C; Grothe MJ; Mukherjee S; Jelistratova I; Jansen I; van Loenhoud AC; Risacher SL; Saykin AJ; Mac Donald CL; Mez J; Trittschuh EH; Gryglewski G; Lanzenberger R; Pijnenburg YAL; Barkhof F; Scheltens P; van der Flier WM; Crane PK; Ossenkoppele R
    Neuroimage Clin; 2021; 30():102660. PubMed ID: 33895633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Greater medial temporal hypometabolism and lower cortical amyloid burden in ApoE4-positive AD patients.
    Lehmann M; Ghosh PM; Madison C; Karydas A; Coppola G; O'Neil JP; Huang Y; Miller BL; Jagust WJ; Rabinovici GD
    J Neurol Neurosurg Psychiatry; 2014 Mar; 85(3):266-73. PubMed ID: 23965289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic correlates of reserve and resilience in MCI due to Alzheimer's Disease (AD).
    Bauckneht M; Chincarini A; Piva R; Arnaldi D; Girtler N; Massa F; Pardini M; Grazzini M; Efeturk H; Pagani M; Sambuceti G; Nobili F; Morbelli S
    Alzheimers Res Ther; 2018 Apr; 10(1):35. PubMed ID: 29615111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of individual-based FDG-PET volume of interest in predicting conversion from mild cognitive impairment to dementia.
    Huang SH; Hsiao WC; Chang HI; Ma MC; Hsu SW; Lee CC; Chen HJ; Lin CH; Huang CW; Chang CC
    BMC Med Imaging; 2024 Mar; 24(1):75. PubMed ID: 38549082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two distinct pathological substrates associated with MMSE-pentagons item deficit in DLB and AD.
    Beretta L; Caminiti SP; Santangelo R; Magnani G; Ferrari-Pellegrini F; Caffarra P; Perani D
    Neuropsychologia; 2019 Oct; 133():107174. PubMed ID: 31446008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons.
    Knopman DS; Jack CR; Wiste HJ; Lundt ES; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Roberts RO; Boeve BF; Petersen RC
    Neurobiol Aging; 2014 Sep; 35(9):2096-106. PubMed ID: 24702820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDG PET and MRI in logopenic primary progressive aphasia versus dementia of the Alzheimer's type.
    Madhavan A; Whitwell JL; Weigand SD; Duffy JR; Strand EA; Machulda MM; Tosakulwong N; Senjem ML; Gunter JL; Lowe VJ; Petersen RC; Jack CR; Josephs KA
    PLoS One; 2013; 8(4):e62471. PubMed ID: 23626825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical profiles of dementia with Lewy bodies with and without Alzheimer's disease-like hypometabolism.
    Chiba Y; Fujishiro H; Ota K; Kasanuki K; Arai H; Hirayasu Y; Sato K; Iseki E
    Int J Geriatr Psychiatry; 2015 Mar; 30(3):316-23. PubMed ID: 24839913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional Disconnection in Alzheimer Dementia and Amyloid-Positive Mild Cognitive Impairment: Association Between EEG Functional Connectivity and Brain Glucose Metabolism.
    Smailovic U; Koenig T; Savitcheva I; Chiotis K; Nordberg A; Blennow K; Winblad B; Jelic V
    Brain Connect; 2020 Dec; 10(10):555-565. PubMed ID: 33073602
    [No Abstract]   [Full Text] [Related]  

  • 14. Varying Degrees of Temporoparietal Hypometabolism on FDG-PET Reveal Amyloid-Positive Logopenic Primary Progressive Aphasia is not a Homogeneous Clinical Entity.
    Krishnan K; Machulda MM; Whitwell JL; Butts AM; Duffy JR; Strand EA; Senjem ML; Spychalla AJ; Jack CR; Lowe VJ; Josephs KA
    J Alzheimers Dis; 2017; 55(3):1019-1029. PubMed ID: 27802232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tracking the progression of Alzheimer's disease: Insights from metabolic patterns of SOMI stages.
    Brugnolo A; Orso B; Girtler N; Ferraro PM; Arnaldi D; Mattioli P; Massa F; Famà F; Argenti L; Biffa G; Morganti W; Buonopane S; Uccelli A; Morbelli S; Pardini M
    Cortex; 2024 Feb; 171():413-422. PubMed ID: 38113612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes and elevated hemoglobin A1c levels are associated with brain hypometabolism but not amyloid accumulation.
    Roberts RO; Knopman DS; Cha RH; Mielke MM; Pankratz VS; Boeve BF; Kantarci K; Geda YE; Jack CR; Petersen RC; Lowe VJ
    J Nucl Med; 2014 May; 55(5):759-64. PubMed ID: 24652830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease.
    Oh H; Madison C; Baker S; Rabinovici G; Jagust W
    Brain; 2016 Aug; 139(Pt 8):2275-89. PubMed ID: 27190008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitively defined Alzheimer's dementia subgroups have distinct atrophy patterns.
    Crane PK; Groot C; Ossenkoppele R; Mukherjee S; Choi SE; Lee M; Scollard P; Gibbons LE; Sanders RE; Trittschuh E; Saykin AJ; Mez J; Nakano C; Donald CM; Sohi H; ; Risacher S
    Alzheimers Dement; 2024 Mar; 20(3):1739-1752. PubMed ID: 38093529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional Amyloid-β Load and White Matter Abnormalities Contribute to Hypometabolism in Alzheimer's Dementia.
    Schilling LP; Pascoal TA; Zimmer ER; Mathotaarachchi S; Shin M; de Mello Rieder CR; Gauthier S; Palmini A; Rosa-Neto P;
    Mol Neurobiol; 2019 Jul; 56(7):4916-4924. PubMed ID: 30414086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer's disease.
    Drzezga A; Grimmer T; Henriksen G; Stangier I; Perneczky R; Diehl-Schmid J; Mathis CA; Klunk WE; Price J; DeKosky S; Wester HJ; Schwaiger M; Kurz A
    Neuroimage; 2008 Jan; 39(2):619-33. PubMed ID: 17962045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.